When was Nectome founded?

Nectome was founded in 2015 and raised its 1st funding round 3 years after it was founded.

Where is Nectome located?

Nectome is headquartered in San Francisco, United States.

Who is the current CEO of Nectome?

Robert McIntyre of Nectome. They have also founded 1 company.

Is Nectome a funded company?

Nectome is a funded company, having raised a total of $***** in its 1st and only funding round, a Seed round on 2018.

When was the latest funding round of Nectome?

Nectome's latest funding was a $***** Seed round on 2018, with participation from 1 investor. Its primary sector is Life Sciences Platforms and Tools. In United States, the Life Sciences Platforms and Tools sector has seen $891M in funding in 2026 to date.

Where does Nectome rank among its competitors?

Nectome ranks 11th amongst 57 active competitors, of which 12 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Cellbox Solutions, which secured $4.07M in Mar, 2026.

Who are the top competitors of Nectome?

Nectome's top competitors include Brooks Automation, Atelerix and Hemanext. Among them, Cellbox Solutions secured the most recent funding round in March, 2026.

Nectome - 2026 Company Profile, Team, Funding & Competitors

Nectome is a seed company based in San Francisco (United States), founded in 2015 by Robert McIntyre and Michael McCanna. It operates as a Provider of biological preservation techniques for preserving the brain. Nectome has raised an undisclosed amount in funding. The company has 57 active competitors, including 12 funded and 8 that have exited. Its top competitors include companies like Brooks Automation, Atelerix and Hemanext.

Company Details

Provider of biological preservation techniques for preserving the brain. The company uses chemical fixative glutaraldehyde to rapidly solidify synapses and prevent decay. The glutaraldehyde rapidly binds to everything it can, transforming the brain from a soft, watery consistency to that of soft rubber. This process is called fixation and has been used for decades to preserve biological samples including brains, various organs, and even entire animals. The preserved brain is then vitrified by storing it at -122°C for long-term preservation.

Website: nectome.com
Email ID: *****@nectome.com

Key Metrics

Founded Year

2015

Location

San Francisco, United States

Stage

Seed

Latest Funding Round

Seed, 2018, $*****

Investors

Utopian & 3 more

Ranked

11^th among 57 active competitors

Similar Companies

Brooks Automation & 69 more

View Nectome's full profile

Nectome has raised funding over 1 round. Its latest funding round was a Seed round on 2018 for $*****. 1 investor participated in its latest round. Nectome has 4 institutional investors.

Here is the list of recent funding rounds of Nectome:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
2018	6164	Seed	4409	6873	4796	6082

Access funding benchmarks and valuations. Sign up today!

View details of Nectome's funding rounds and investors

The founders of Nectome are Robert McIntyre and Michael McCanna. Robert McIntyre is the CEO of Nectome.

Here are the details of Nectome's key team members:

Robert McIntyre: Co-Founder & CEO of Nectome. They serve on the board of 1 company.
Contact Info: 1 email address and 1 phone number
Michael McCanna: Co-Founder of Nectome.

View details of Nectome's Founder profiles and Board Members

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Nectome include Brooks Automation, Atelerix and Hemanext. Here is the list of Top 10 competitors of Nectome, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Brooks Automation 1978, Chelmsford (United States), Public	Provider of automation and contamination control solutions for manufacturing industries	-	Western Technology Investment, Natural Bridges Ventures ... & 3 others	59/100
2nd	Atelerix 2017, Newcastle Upon Tyne (United Kingdom), Seed	Develops technology for storage and transportation of cells	$2.43M	UK Innovation Science & Seed Fund, Mandashi ... & 35 others	58/100
3rd	Hemanext 2004, Lexington (United States), Series B	Developer of technologies to store blood and its products	$128M	HHS	54/100
4th	BlackFrog Technologies 2015, Manipal (India), Seed	Provider of a portable temperature-regulated carrier for biologicals cold‑chain delivery solutions	$2.01M	Manipal Group, Social Alpha & 11 others	51/100
5th	Cellbox Solutions 2016, Lubeck (Germany), Series A	Provider of a portable device for cells storage and transport purposes	$11.1M	Companisto, NRW.Bank & 8 others	49/100
6th	Cold Chain Technologies 2001, Franklin (United States), Acquired	Provider of temperature analysis, cold chain monitoring, and other related services	-	The Cambria Group	47/100
7th	ThermoSafe 2002, San Antonio (United States), Acquired	Temperature-controlled packaging solutions for safe, efficient transport of sensitive products	-	-	46/100
8th	Longhorn Vaccines and Diagnostics 2006, Bethesda (United States), Unfunded	Provider of diagnostic solutions to diagnose and treat a wide range of diseases	-	-	43/100
9th	DeltaTrak 1989, Pleasanton (United States), Unfunded	Cold chain monitoring solutions ensuring supply chain integrity and product safety	-	-	39/100
10th	Transplant Biomedicals 2014, Barcelona (Spain), Series A	Organ transport devices	$4.24M	Caixa Capital Risc, Kereon Partners	33/100
11th	Nectome 2015, San Francisco (United States), Seed	Provider of biological preservation techniques for preserving the brain	-	Utopian, Toy Ventures & 2 others	37/100